Drug Shortage Report for BOOSTRIX-POLIO

Last updated on 2017-12-07 History

Report ID	19888
Drug Identification Number	02312557
Brand name	BOOSTRIX-POLIO
Common or Proper name	Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine
Company Name	GLAXOSMITHKLINE INC
Market Status	MARKETED
Active Ingredient(s)	INACTIVATED POLIOVIRUS TYPE I INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE III TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED PERTUSSIS TOXOID ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTACTIN ADSORBED
Strength(s)	40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG
Dosage form(s)	SUSPENSION
Route of administration	INTRAMUSCULAR
Packaging sizes (GTIN) Click here to see a list of all reports for this drug.	(See additional packaging sizes)
Additional packaging sizes	10's
ATC code	J07CA
ATC description	BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage	Delay in shipping of the drug.
Anticipated start date
Actual start date	2017-11-08
Estimated end date	2017-12-07
Actual end date	2017-12-06
Shortage status	Resolved
Updated date	2017-12-07
Company comments	Supply released November 10, 2017 with limited quantity.
Health Canada comments
Tier 3 Status	No
Company contact information	1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 26